Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 18

Results For "TB"

243 News Found

Dr. Mansukh Mandaviya chairs celebrations of Ayushman Bharat health and wellness centres
Public Health | April 17, 2022

Dr. Mansukh Mandaviya chairs celebrations of Ayushman Bharat health and wellness centres

Dr. Mansukh Mandaviya launches a quarterly report on AB-HWCs, Guidelines on Human resources for health, Public Health Management Cadre’ Guidance for implementation and Indian Public Health Standards Guidelines; interacts with healthcare workers from across the country


CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
Biotech | April 11, 2022

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid

These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection


LivaNova initiates targeted commercial launch of Essenz patient monitor
Biotech | April 10, 2022

LivaNova initiates targeted commercial launch of Essenz patient monitor

An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe


India Pharmaceutical Market reports revenue decline in March 2022
News | April 10, 2022

India Pharmaceutical Market reports revenue decline in March 2022

Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect


IAVI and Moderna partner to tackle broad global health priorities
Biotech | April 08, 2022

IAVI and Moderna partner to tackle broad global health priorities

Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis


Indian pharma growth likely to moderate in FY23: ICRA
News | April 07, 2022

Indian pharma growth likely to moderate in FY23: ICRA

Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23


Feedback Medical brings Bleepa to India
Digitisation | April 05, 2022

Feedback Medical brings Bleepa to India

Announces pilot project for rapid, remote diagnosis of tuberculosis


We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India
interviews | March 30, 2022

We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India

Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com


USFDA approves EUA for second booster dose of Moderna
News | March 29, 2022

USFDA approves EUA for second booster dose of Moderna

50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age


SRL Diagnostics launches whole genome sequencing test for Tuberculosis
Diagnostic Center | March 24, 2022

SRL Diagnostics launches whole genome sequencing test for Tuberculosis

The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step